Ticker
CNTXCompany Name
CONTEXT THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 87.15M | $ 83.52M | 95.83% |
3/31/2025 | $ 92.97M | $ 89.35M | 96.11% |
12/31/2024 | $ 98.13M | $ 94.43M | 96.23% |
9/30/2024 | $ 86.33M | $ 84.8M | 98.23% |
6/30/2024 | $ 102.71M | $ 101.54M | 98.86% |
3/31/2024 | $ 11.05M | $ 10.09M | 91.29% |
12/31/2023 | $ 16.06M | $ 14.45M | 89.96% |
9/30/2023 | $ 22.99M | $ 21.68M | 94.29% |
6/30/2023 | $ 27.76M | $ 25.14M | 90.55% |
3/31/2023 | $ 31.97M | $ 29.77M | 93.13% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CONTEXT THERAPEUTICS INC is calculated as follows: CashnEq [ $ 341.04K ] / Assets [ $ 467.34K ]
(=) Cash to Assets [ 72.97% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.93K |
---|---|
min | 0% |
max | 40.71% |
average | 9.77% |
median | 6.41% |
std | 9.51% |